首页> 外国专利> SHORT NUCLEIC ACID MOLECULE-MEDIATED MODULATION OF AURORA B KINASE EXPRESSION AND COMBINATIONS FOR USE IN ANTICANCER THERAPY

SHORT NUCLEIC ACID MOLECULE-MEDIATED MODULATION OF AURORA B KINASE EXPRESSION AND COMBINATIONS FOR USE IN ANTICANCER THERAPY

机译:短核酸介导的Auror B激酶表达及其组合在抗癌药物治疗中的应用

摘要

This invention relates to the use of short nucleic acid molecules that modulate Aurora-B kinase (AurkB) expression. The invention includes compounds, compositions and methods useful for the modulation of expression and activity of genes involved in the AurkB pathway. In one embodiment, the present invention provides short nucleic acid molecules, such as siRNA, which can be used in treating, preventing, or inhibiting cancer, and any other proliferative disease, trait or condition, which respond to a reduction in AurkB expression in a cell or tissue. Such short nucleic acid molecules can be used alone or in combination with other treatments or therapies, including short nucleic acid molecules that modulate expression of EGFR.
机译:本发明涉及调节Aurora-B激酶(AurkB)表达的短核酸分子的用途。本发明包括用于调节参与AurkB途径的基因的表达和活性的化合物,组合物和方法。在一个实施方案中,本发明提供了短核酸分子,例如siRNA,其可用于治疗,预防或抑制癌症以及任何其他增生性疾病,性状或病症,其响应于AurkB表达的降低。细胞或组织。此类短核酸分子可单独使用或与其他治疗或疗法结合使用,包括调节EGFR表达的短核酸分子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号